Direct analysis of sterols from dried plasma/blood spots by an atmospheric pressure thermal desorption chemical ionization mass spectrometry (APTDCI-MS) method for a rapid screening of Smith–Lemli–Opitz syndrome
- 19 January 2010
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 135 (4) , 789-796
Abstract
Here is proposed a rapid and sensitive method involving atmospheric pressure thermal desorption chemical ionization mass spectrometry (APTDCI-MS) for specific laboratory screening of the Smith–Lemli–Opitz syndrome (SLOS), an inherited defect of cholesterol biosynthesis. Biochemical findings in the blood of SLOS patients are low cholesterol (Chol), high 7- and 8-dehydrocholesterol (DHCs) levels and high DHCs/Chol ratios. The APTDCI proposed method is able to ionize sterols for qualitative and quantitative analysis directly from dried plasma/blood spots. Critical APTDCI parameters – desolvation gas flow and temperature – were optimized analyzing Chol, 7-DHC and cholesteryl stearate standards spotted onto a glass slide acquiring the full scan spectra in positive ion mode. Chol levels in dried plasma spots of unaffected controls (n = 23) obtained by the proposed method were compared with those of the enzymatic method (y = 0.9166x + 0.3811; r = 0.8831) while Chol and DHCs of SLOS patients (n = 9) were compared with the gas chromatography flame ionization detection (GC-FID) method (y = 0.8214x + 0.7388; r = 0.8288). The APTDCI-MS method is also able to differentiate normal from SLOS samples directly analyzing whole blood and washed red cells spotted on paper. In conclusion, the intrinsic analytical high-throughput of APTDCI-MS method for sterol analysis could be useful to screen SLO syndrome.Keywords
This publication has 37 references indexed in Scilit:
- Potential of Sterol Analysis by Liquid Chromatography–Tandem Mass Spectrometry for the Prenatal Diagnosis of Smith-Lemli-Opitz SyndromeClinical Chemistry, 2008
- Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populationsJournal of Medical Genetics, 2007
- DHCR7 mutation carrier rates and prevalence of the RSH/Smith‐Lemli‐Opitz syndrome: Where are the patients?American Journal of Medical Genetics Part A, 2006
- Mutations in the Human Sterol Δ7-Reductase Gene at 11q12-13 Cause Smith-Lemli-Opitz SyndromeThe American Journal of Human Genetics, 1998
- Molecular cloning and expression of the human Δ7-sterol reductaseProceedings of the National Academy of Sciences, 1998
- A new face for an old syndromeAmerican Journal of Medical Genetics, 1997
- Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes.Journal of Clinical Investigation, 1995
- Defective Cholesterol Biosynthesis Associated with the Smith-Lemli-Opitz SyndromeNew England Journal of Medicine, 1994
- Smith‐Lemli‐Opitz (RSH) syndrome bibliographyAmerican Journal of Medical Genetics, 1987
- A newly recognized syndromeof multiple congenital anomaliesThe Journal of Pediatrics, 1964